Moderna
MRNA
#1792
Rank
โ‚น992.37 B
Marketcap
โ‚น2,540
Share price
0.97%
Change (1 day)
-34.43%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -โ‚น270.01 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น2.20 Billion. In 2024 the company made an earning of -โ‚น322.24 Billion, an increase over its 2023 earnings that were of -โ‚น351.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น270.01 Billion-16.21%
2024 -โ‚น322.24 Billion-8.22%
2023 -โ‚น351.11 Billion-140.65%
2022 โ‚น863.73 B-27.81%
2021 โ‚น1.196 T-1911.15%
2020 -โ‚น66.06 Billion44.7%
2019 -โ‚น45.66 Billion28.63%
2018 -โ‚น35.49 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-โ‚น4.27 Billion-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.076 T-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น3.76 Billion-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.72 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.476 T-622.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
-โ‚น6.76 Billion-97.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.913 T-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น10.59 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA